E-Poster Viewing

EPV239 - THE LEEDS TEACHING HOSPITALS TRUST EXPERIENCE OF SPINAL CORD STIMULATION: A RETROSPECTIVE EVALUATION IN CHRONIC PAIN CONDITIONS (ID 282)

Session Name
E-Poster Viewing
Presenter
  • Beatrice Bretherton, United Kingdom
Authors
  • G. Baranidharan, United Kingdom
  • Beatrice Bretherton, United Kingdom
  • Tracey Crowther, United Kingdom
  • Thomas Kay, United Kingdom
  • Nathan Marsh, United Kingdom
  • Bethan Roberts, United Kingdom
  • Charlotte Romanis, United Kingdom
Presentation Number
EPV239
Presentation Topic
13. Late-Breaking Research

Abstract

Introduction

Since 1967, spinal cord stimulation (SCS) has been increasingly used in the treatment of chronic pain. Large numbers of patients are implanted with a SCS in the UK: around 34,000 patients per year. Approximately 180 of these are carried out in the Leeds Teaching Hospitals NHS Trust (LTHT). Most studies, typically prospective trials, have demonstrated that SCS is effective and safe in a number of diagnoses, including failed back surgery syndrome (1), failed neck surgery syndrome (2), complex regional pain syndrome (3), painful diabetic neuropathy (4), fibromyalgia (5) along with many others. Using real-world data, this study investigated the efficacy and complications associated with SCS in failed back surgery syndrome (FBSS) and chronic visceral pain in a teaching hospital.

Methods/Materials

This was a retrospective evaluation, with data collected from patients with failed back surgery syndrome or chronic visceral pain who received 10 kHz or BurstDR SCS from March 2012-March 2020 in LTHT. The following data were ascertained from paper files and hospital electronic records: gender, age, chronic pain diagnosis, SCS system, implant date, baseline and follow-up scores for average pain (visual analogue scale, VAS), worst pain (VAS) and health-related quality of life (EQ-5D), and the occurrence of revisions and explants. Data were statistically analysed by paired t-tests (or Wilcoxon signed-rank tests for non-normally distributed data). Descriptive statistics, counts and percentages were also generated.

Results

Four hundred and forty-five patients with FBSS or chronic visceral pain received fully implanted 10 kHz or burst SCS. Eleven patients were waiting for their first follow-up and three patients were lost to follow-up. Fifty-one patients had an explantation and six were waiting for explantation of their system. This resulted in a final sample of 374 patients. Average pain (p < 0.001), worst pain (p < 0.001) and QoL (p < 0.001) were significantly improved at follow-up compared to baseline. The mean (SD) change in average pain, worst pain and QoL were -2.35 (2.36 cm), -2.04 (2.33 cm) and 0.30 (0.44) respectively. Remission (0-3cm average pain VAS, (6)) occurred in 23% (98 of 421) of patients and 27% (108 of 398) reported reductions ≥50% in average pain at follow-up. Fifty-three patients (of 374, 14%) underwent a revision with IPG or anchor site pain being the most common reason for revision (n = 27). In total, 51 (of 445, 11%) patients underwent a full system explantation. Insufficient pain relief was the most common reason for explant (n = 42), followed by infection (n = 8) and requiring an MRI (n = 2). IPG site pain was cited as a secondary influential factor for explantation in seven cases.

Discussion

Findings demonstrated that SCS in FBSS and chronic visceral pain were effective at reducing pain and improving QoL. Importantly, an assessment of surgical revisions and explants showed this treatment is safe in these conditions.

Conclusions

By using real-world data, it is hoped that findings from this retrospective study will broaden insight into the clinical practice of SCS in FBSS and chronic visceral pain.

References

1. Al-Kaisy A, Van Buyten J-P, Smet I, Palmisani S, Pang D, Smith T. Sustained Effectiveness of 10 kHz High-Frequency Spinal Cord Stimulation for Patients with Chronic, Low Back Pain: 24-Month Results of a Prospective Multicenter Study. Pain Med [Internet]. 2014 Mar 1;15(3):347–54. Available from: https://academic.oup.com/painmedicine/article-lookup/doi/10.1111/pme.12294

2. De Ridder D, Plazier M, Kamerling N, Menovsky T, Vanneste S. Burst Spinal Cord Stimulation for Limb and Back Pain. World Neurosurg [Internet]. 2013 Nov;80(5):642-649.e1. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1878875013001010

3. Kriek N, Groeneweg JG, Stronks DL, de Ridder D, Huygen FJPM. Preferred frequencies and waveforms for spinal cord stimulation in patients with complex regional pain syndrome: A multicentre, double-blind, randomized and placebo-controlled crossover trial. Eur J Pain [Internet]. 2017 Mar;21(3):507–19. Available from: http://doi.wiley.com/10.1002/ejp.944

4. de Vos CC, Bom MJ, Vanneste S, Lenders MWPM, de Ridder D. Burst Spinal Cord Stimulation Evaluated in Patients With Failed Back Surgery Syndrome and Painful Diabetic Neuropathy. Neuromodulation Technol Neural Interface. 2014 Feb;17(2):152–9.

5. Salmon J. High-frequency spinal cord stimulation at 10 kHz for widespread pain: a retrospective survey of outcomes from combined cervical and thoracic electrode placements. Postgrad Med [Internet]. 2019 Apr 3;131(3):230–8. Available from: https://www.tandfonline.com/doi/full/10.1080/00325481.2019.1587564

6. De Jaeger M, Goudman L, Eldabe S, Van Dongen R, De Smedt A, Moens M. The association between pain intensity and disability in patients with failed back surgery syndrome, treated with spinal cord stimulation. Disabil Rehabil [Internet]. 2019 Nov 24;1–7. Available from: https://www.tandfonline.com/doi/full/10.1080/09638288.2019.1694084

Hide